IDWeek 2024

IDWeek 2024

Doblado-Maldonado A, et al.

Real-world Virologic and Safety Outcomes in People Living with HIV-1 Using Dolutegravir (DTG) + Lamivudine (3TC) in Asia Stratified by Viral Load (VL), Including in Individuals with High VLs

Navigate to: